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Assessment of morbidity from complete axillary dissection
D. Ivens, A.L. Hoe, T.J. Podd, C.R. Hamilton, I. Taylor & G.T. Royle
Wessex Radiotherapy Centre, Royal South Hants Hospital, Lyon Street, Southampton S09 4PE, UK.
Summary The importance of axillary dissection as part of the primary surgical procedure in the treatment of
operable cases of carcinoma of the breast is established. The morbidity of this procedure, however, is less well
documented.
A study of 126 women who had had full axillary dissection as part of their initial surgical treatment was
undertaken to assess their degree of morbidity in terms of numbness, pain, weakness, swelling, and stiffness.
Seventy per cent of cases complained of numbness, 33% of pain, 25% ofweakness, 24% of limb swelling, and
15% of stiffness. Objective measurements confirmed decreased sensation in 81%, weakness in 27%, swelling in
10%, and stiffness in 10%. In no case were these symptoms described as severe, though they did have an effect
upon the daily lives of 39%.
The side effects of full axillary dissection are common and all women should be warned of them prior to
surgery; however they are usually mild and therefore should not preclude this procedure as a part of definitive
surgical treatment.
Axillary dissection has a role in the management of early
breast cancer as a major prognostic indicator (Fisher &
Slack, 1970), as a guide to the need for adjuvant treatments
(Yarnold, 1984), and therapeutically in reducing the risk of
axillary recurrence (Graversen et al., 1988; Kissin et al., 1982;
Cady & Sear, 1986). It may not, however, influence overall
survival rates and knowledge of the morbidity of the proce-
dure is therefore important (Kissin et al., 1986; Brismar &
Ljungdahl, 1983; Vecht et al., 1989; Aitken et al., 1989;
Andry et al., 1980; Christensen & Lundgren, 1989). The
value of complete axillary dissection, as opposed to nodal
sampling or partial dissections, is twofold. Firstly it reduces
the risk of local axillary recurrence to less than 5%, lesser
procedures carrying a proportionally higher risk of local
recurrence, and secondly its predictive value, both of prog-
nosis, and of the necessity for additional axillary
radiotherapy, is greater.
This study was performed to assess the morbidity follow-
ing axillary dissection in terms of numbness, pain, weakness,
swelling, and stiffness, both subjectively and objectively.
Material and methods
One hundred and twenty-six consecutive patients attending a
Breast Clinic between December 1990 and April 1991 who
fulfilled the following criteria were invited to participate in
the study.
(1) Had undergone full axillary dissection at six months
previously.
(2) Had not received radiotherapy to the axilla.
(3) Had no evidence of locoregional or distant recurrence.
(4) Had not received chemotherapy.
Those who agreed to participate completed a questionnaire
asking them to record current problems with pain, weakness,
numbness, swelling, and stiffness in the treated arm. Those
who complained of these were asked in each case; (1) if it
affected their day to day living, and (2) in the case of
stiffness, pain and swelling, to grade the problem from mild
to severe.
Measurements were then carried out on both arms, using
the untreated one as a control. Arm volume was estimated in
two ways. Firstly the woman was asked to stand with her
hands on her hips to fix the olecranon. A mark was made
15 cm above and 10cm below this level. These two points
were chosen to allow comparison with other studies. The
circumference at these two points was measured. The woman
was then asked to dip each arm into a displacement tank
filled with warm water up to the first mark and hold it there
until all the water had drained out into a measuring cylinder.
The volume was noted and she was then asked to immerse
the arm up the higher level and the amount of water dis-
placed was again recorded. In this study a difference in
volume between treated and untreated arm of 200ml was
chosen as the cut off point to define arm oedema to allow
closer comparison with other studies (Kissin et al., 1986).
Mobility was assessed by asking the woman to raise each
hand as high above her head as possible and measuring the
angle of abduction from behind. There are obvious limita-
tions with this method since this movement involves the
scapula as well as the gleno-humeral joint, but its limitation
does correlate well with symptoms.
Strength was measured by asking the woman to squeeze a
surgical hand grip with each hand in turn and the higher of
two readings taken. Numbness was assessed by comparing
the sensitivities of both arms, shoulders, axillae, and lateral
chest walls to light touch using cotton wool and pin prick. If
there was a difference, it was recorded as either partial or
total loss by hatching in the corresponding area on a diag-
ram.
Fifteen female medical staff and untreated patients had the
same measurements of arm volume, strength, and mobility
carried out to represent a separate control group.
The following definitions were used in analysing the
results:
Arm swelling: difference in volume between treated and
untreated arm at 15 cm above the olecranon of equal
to or greater than 200 ml.
Weakness: greater than 4 kg equivalent on hand grip
difference between treated and untreated arms.
Numbness: decreased sensitivity to either cotton wool or
pinprick on treated arm, shoulder, axilla, or lateral
chest wall.
Stiffness: difference in abduction between treated and un-
treated arms of equal or greater than 10 degrees.
Results
One hundred and twenty-six patients answered the question-
naire and of these 106 had the above measurements taken.
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The mean age of the respondants was 56 years (range
28-80) of whom 70% were postmenopausal and 55% had
received treatment on their dominant side.
The mean age of the 15 controls was 52 years (range
29-74). The results are presented graphically to show:
(1) Symptoms as reported on the questionnaire (Figure 1),
with numbness affecting the majority (70%), whereas pain,
weakness, swelling, and stiffness each affected less than one
third of the patients.
(2) The variation of pain with time from surgery (Figure 2),
showing a gradual and consistant decrease with time,
although this was not statistically significant.
(3) The variation of arm swelling with time (Figure 3), show-
ing a tendency to increase both subjectively, and objectively,
over the first two or four years after surgery and decreasing
thereafter.
(4) The variation of stiffness with time (Figure 4), showing a
consistently low level of incidence that does not vary
significantly over the first four years after surgery.
(5) The variation of numbness with time both subjectively
(Figure 5), and objectively (Figure 6), confirming a tendency
to mitigate with time.
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(6) The variation of weakness with time (Figure 7), which
has a mean incidence of 27% and does not vary significantly
with time.
Of the 126 respondants to the questionnaire, their symp-
toms were sufficiently severe to interfere with daily living in
the following proportions; Pain 9%
Swelling 80%
Stiffness 4%
Weakness 130%
The Chi-square test was then used to determine whether or
not there was any linkage between the above symptoms and
the following variables; menopausal status, dominant/
nondominant side, type of surgery (local excision/mast-
ectomy), surgical complications, axillary node status, time
after surgery, and patient age. Significance was reached in the
following subsets: Swelling was more common following
operation on the dominant side (l18%) than the non-
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dominant side (2%). (P = 0.028), as was weakness (37% vs
17%; P=0.037).
However numbness, specifically over the lateral chest wall,
was less common on the dominant (21%) than on the non
dominant (46%) side (P = 0.014).
Whilst the graphs in Figures 2, 5, and 6 suggest that pain
and numbness tend to decrease with time, the results do not
quite achieve statistical significance (P = 0.076 and P = 0.12
respectively).
None ofthe fifteen control patients gave results outside the
reference ranges as defined above.
Discussion
The place and extent of axillary dissection in the manage-
ment of early breast cancer remains controversial (Fentiman
& Mansell, 1991), and its effect upon long term survival
unproven. Morbidity is therefore of major concern. The
advantages of full axillary dissection, as opposed to lymph
node sampling or lower level dissections, are that it reduces
the risk of axillary recurrence to less than 5%, allows more
accurate prediction of prognosis and need for adjuvant
treatments, and provided that no more than 75% of the
removed nodes are histologically positive for metastatic
disease, allows axillary radiotherapy to be held in reserve,
with consequent reduction in overall morbidity.
The above results show that the side effects of full axillary
dissection, including numbness, weakness, pain, swelling, and
stiffness are common and so should be mentioned at the time
of obtaining consent for the operative procedure. However
they also tend to be mild, affecting daily living in approxi-
mately one third of patients, and to mitigate with time albeit
not to a statistically significant degree in this study. They also
suggest strongly that certain side effects, namely swelling and
weakness, are more likely to occur if the dominant side is
operated upon, whereas numbness is less likely to result. The
explanation for these observations is unclear but may be due
to chance alone.
The literature concerning the morbidity of management
regimes involving incomplete axillary dissections and routine
nodal radiotherapy is insufficient to allow direct comparison
with the above group and a controlled clinical trial designed
so to do would be most unlikely to win ethical approval.
Moreover the problems associated with treatment of local
axillary relapse in clinical practice highlight the desirability of
securing local control from the outset.
In summary the morbidity of full axillary dissection is
quantifiable, significant, but seldom severe and, in the
opinion of the authors, should not be considered sufficient to
outweigh the advantages of improved local control and
added prognostic information provided.
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